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Abstract
Older adults with cancer represent a complex patient population. Geriatric assessment (GA) is 
recommended to evaluate the medical and supportive care needs of this group. “GA with 
management” is a term encompassing the resultant medical decisions and interventions 
implemented in response to vulnerabilities identified on GA. In older, non-cancer patients, GA 
with management has been shown to improve a variety of outcomes, such as reducing functional 
decline and health care utilization. However, the role of GA with management in the older adult 
with cancer is less well established. Rigorous clinical trials of GA with management are necessary 
to develop an evidence base and support its use in the routine oncology care of older adults. At the 
recent U-13 conference, “Design and Implementation of Intervention Studies to Improve or 
Maintain Quality of Survivorship in Older and/or Frail Adults with Cancer,” a session was 
dedicated to developing research priorities in GA with management. Here we summarize 
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identified knowledge gaps in GA with management studies for older patients with cancer and 
propose areas for future research.
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1. Introduction
Older patients with cancer are a heterogeneous group, and chronologic age does not 
necessarily reflect physiologic age in this population. GA should be utilized in determining a 
patient’s fitness for cancer treatment and developing a personalized treatment plan.1 GA is a 
set of tools to assess a variety of domains that commonly impact older adults, including 
physical function, comorbidity and polypharmacy, nutrition, cognitive function, social 
support, and psychological status. GA can provide a comprehensive assessment of a 
patient’s overall health status and identify potential areas of vulnerability. In non-cancer 
patients, geriatricians recognize these areas of vulnerabilities and develop goal-directed 
interventions in response to GA impairments to potentially improve outcomes. “GA with 
management” describes the resultant medical decisions and interventions implemented in 
response to vulnerabilities identified on GA. In older patients with cancer, GA can be 
incorporated into routine oncology evaluation. Items contained in the GA predict 
chemotherapy toxicity, and GA has been shown to influence decision making for cancer 
treatments. However, GA has not yet been routinely used to develop goal-directed 
interventions and guide management in older patients with cancer. Although there are data 
to support the benefit of GA with management interventions in the non-cancer population, 
the optimal approach for developing and implementing these interventions in older patients 
with cancer is not established. Because oncologists are not always familiar with the 
geriatrics literature and may not be willing to extrapolate information from the non-cancer 
population, knowledge about the feasibility and benefit of GA with management in 
oncology will be important to move the field forward. Data supporting the impact of GA 
with management on cancer-specific as well as non-cancer-specific outcomes will be 
necessary to support utilization of geriatric assessment and management as a standard of 
care for older patients with cancer. Here we summarize research priorities for GA with 
management discussed at the recent U-13 conference “Design and Implementation of 
Intervention Studies to Improve or Maintain Quality of Survivorship in Older and/or Frail 
Adults with Cancer.” We will review current knowledge on the use of geriatric assessment in 
cancer care, discuss the evidence supporting GA with management in the non-cancer 
population, and summarize knowledge gaps regarding GA with management in older 
patients with cancer and propose mechanisms to fill these knowledge gaps.
1.1. What is Known
1.1.1. Geriatric Assessment in Oncology Care—It is feasible to incorporate GA into 
routine oncology practice. Hurria and colleagues developed a cancer-specific GA, the 
majority of which is completed solely by the patient within 27 min.2 It is also feasible to 
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incorporate GA into a private oncology practice model and community oncology clinics.3,4 
Elements of the GA have also been shown to be predictive of chemotherapy toxicity.5,6 The 
Cancer and Aging Research Group (CARG) developed a predictive model for chemotherapy 
toxicity that includes several GA measures as well as cancer and treatment-specific factors. 
The model was developed in 500 patients with cancer aged ≥65 years and found that 
geriatric-specific risk factors, such as history of falls and needing assistance with taking 
medications, were predictive of grade 3 to 5 chemotherapy toxicity.5 Extermann and 
colleagues also developed a chemotherapy toxicity risk prediction model, the Chemotherapy 
Risk Assessment Scale for High-Age Patients (CRASH) score. The CRASH model also 
included several GA risk factors, such as needing assistance with Instrumental Activities of 
Daily Living (IADL) (e.g., meal preparation or housework) and impaired cognition (Mini 
Mental Status Exam [MMSE] score < 30), which were predictive of chemotherapy toxicity.6 
GA is influential in clinical decision making. Hamaker and colleagues conducted a 
systematic review of the effect of GA on treatment decision making in older patients with 
cancer. They identified six studies that addressed a change in oncologic treatment and found 
that the initial treatment plan was modified in 39% of patients based on GA results.7
1.1.2. Geriatric Assessment with Management Intervention—GA with 
management improves a variety of outcomes in older, non-cancer patients. In a study by 
Frese and colleagues of 1620 community-dwelling adults aged 70 years and over, 
individuals randomized to GA with management interventions had a 22.3% decreased risk 
of death. The risk of nursing home placement was also lower in the intervention group.12 
The DEED II study demonstrated that GA with implementation of geriatric management 
interventions for community-dwelling older adults with a recent Emergency Room (ER) 
visit produced lower rates of hospitalization at 30 days and 18 months following the initial 
ER visit. The management intervention group maintained better physical and mental 
function at 6-month follow-up than the control group.13 A Cochrane meta-analysis evaluated 
the benefit of comprehensive GA with management program in hospitalized patients and 
included 10,315 patients in six countries. It showed that GA with management improved the 
likelihood that patients would be alive and functionally independent in the community at 6-
month and 12-month follow-up. Rates of institutionalization were lower for patients 
receiving GA with management.14
Other studies have shown less robust benefits from GA with management in the non-cancer 
population. Cohen and colleagues evaluated the impact of inpatient and outpatient GA in 
1388 patients randomized to receive inpatient GA versus usual care, with or without 
outpatient GA follow-up. They found no significant effects on overall survival with the 
intervention; however, the intervention group had significant reductions in functional decline 
and improvements in mental health without an increase in cost.15
Several domain-focused GA with management programs have also been shown to improve 
outcomes in older, non-cancer patients. Multiple studies have evaluated the impact of 
physical function interventions and have been shown to improve a variety of outcomes 
including mobility,16,17 strength,18 balance,19 gait speed19,20 and decrease risk of falls.21 
Focused nutritional interventions have demonstrated improvement in Mini-Nutritional 
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Assessment (MNA) scores and serum albumin levels.22 Keeler and colleagues demonstrated 
that GA with management interventions are cost effective.23
An expert panel of U.S.-based geriatric oncologists recommend incorporation of GA with 
management into clinical care.30 A Delphi process was utilized to develop consensus 
regarding GA with management interventions among experts in the field. The experts met 
consensus on multiple, high-priority GA with management recommendations; however, 
many of these recommendations have not yet been tested in older adults with cancer. GA 
with management recommendations based upon this expert consensus are summarized in 
Table 1.
2. Current Gaps in Knowledge and Mechanisms for Filling Gaps
2.1. Gap 1: What is the Feasibility of Developing and Implementing ga with Management 
Interventions in Cancer Care?
A recent British study evaluated the impact of GA with management in older patients with 
cancer undergoing chemotherapy. In this study, a cohort of patients deemed to be high-risk 
based upon a screening questionnaire (CGA-GOLD) underwent evaluation by a geriatrician 
with implementation of geriatric management interventions. Outcomes of interest included 
grades 3–5 chemotherapy toxicity, rate of completion of cancer treatment as planned, 
treatment modifications, early treatment discontinuation, and death at 6 months. Outcomes 
of the intervention group were compared to a previously evaluated observational cohort. The 
authors determined that patients who received GA with management were more likely to 
complete cancer treatment and required fewer treatment modifications than the observational 
cohort. The overall grade 3–5 chemotherapy toxicity rate was not significantly different 
between the two groups. On average, patients received 6.2 ± 2.6 geriatric management 
interventions (range 0–15).24 However, this model of care relied upon geriatrician 
management, and the feasibility of developing and implementing such interventions 
independent of direct geriatrics involvement is not established.
A small number of trials evaluating GA with management interventions focusing on a single 
GA domain has been conducted in older patients with cancer. A French study evaluated the 
impact of a nutritional counseling program for patients aged ≥70 receiving chemotherapy for 
solid tumor malignancies that were at risk based upon MNA score. The authors found that 
dietary counseling was efficient at increasing caloric intake in this population but had no 
significant effect in mortality or chemotherapy outcomes.25 For older women with breast 
cancer, the impact of a nurse case management intervention program was evaluated in a 
randomized trial. The authors found that patients randomized to the intervention group were 
more likely to receive standard of care therapy (increased rates of breast conserving therapy, 
radiation therapy, reconstruction, and chemotherapy). The effect of the intervention was 
most pronounced in women with indicators of poor social support.26 McCorkle and 
colleagues evaluated the impact of a specialized home care intervention program in older 
post-surgical cancer patients. The intervention involved a 4-week program of home visits 
and telephone calls delivered by advanced practice nurses. The authors found that the nurse-
based intervention improved overall survival, with impact most pronounced in individuals 
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with advanced disease.27 Other studies have demonstrated that GA with management 
improves quality of life and pain management in older cancer patients.28,29
The current evidence for using GA with management in cancer patients is minimal, and it is 
unclear if such interventions can be developed and implemented in an oncology setting 
independent of geriatrician assessment. In the majority of oncology care settings, the 
involvement of geriatricians in cancer care is limited at best. Therefore, models of care need 
to be developed to optimize inclusion of geriatric management principles into oncology 
practice. Feasibility studies need to be developed evaluating various implementation rates of 
GA with management recommendation in various models of care.
In prior studies, implementation rates of GA-based management recommendations were a 
limiting factor. In the systematic review of geriatric assessment by Hamaker and colleagues, 
implementation rates of geriatric management interventions were highest in trials that had a 
standardized intervention protocol or a geriatric consultation. However, in the one study that 
relied on the cancer specialist to implement suggested interventions, only 26% of patients 
received any of the recommendations.7 Clearly, supportive mechanisms for implementing 
recommendations should be developed and evaluated. For geriatric management 
interventions that are referral based (such as physical therapy or home health services), the 
referral process could be automated using electronic health record technology. 
Multidisciplinary members of the oncology care team, such as social workers or nurses, 
could be engaged to implement the geriatric management interventions. For management 
interventions that are education based, for example counseling on fall precautions, videos or 
web modules could be developed and utilized.
2.2. Gap 2: How Does the Benefit of Geriatric Interventions Vary Based Upon Cancer 
Prognosis?
The role of geriatric assessment with management interventions may vary based upon cancer 
prognosis. In patients who are receiving curative intent cancer treatment, or who have a 
longer prognosis, the benefits of GA with management interventions may be similar to those 
in the non-cancer population. For these patients, estimated life expectancy will be of 
sufficient duration to derive the full potential benefit of the proposed intervention. Thus, in 
this group of patients, GA with management interventions may maintain independence and 
reduce functional decline. Amore important and relevant question in this population may be 
how to incorporate GA with management recommendations into clinical care. As cancer 
treatments become increasingly effective and patients are living longer with cancer and 
cancer treatments, GA with management interventions may become a valuable tool for 
optimizing independence and function during cancer therapy and survivorship.
It is also important to understand if GA with management interventions improves the 
tolerance and efficacy of treatments for patients who are receiving cancer therapy. For 
example, in vulnerable patients receiving adjuvant chemotherapy, regimens frequently need 
to be modified or dose reduced due to adverse events. It is unknown if GA with management 
interventions may improve tolerability, thus allowing patients to receive standard of care 
treatment and therefore potentially improving cancer-related outcomes. Randomized studies 
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will be required to determine the impact of GA with management interventions on the 
tolerance and efficacy of cancer therapy regimens.
For patients with shorter cancer-specific survivals (i.e., <1 year), studies of GA with 
management interventions may focus on outcomes such as improvement in quality of life 
and prolongation of active life expectancy.
Therefore, the outcomes of interest vary based upon the clinical setting for GA with 
management. Clinical trial end points should reflect this variability as well. Clinical trials in 
oncology usually have the primary end point of survival, and perhaps this is appropriate in 
the curative intent setting. However, given the supportive care focus of GA with 
management, alternative end points such as chemotherapy toxicity, completion of planned 
therapy, rates of hospitalization, or quality of life may also be appropriate end points. 
Geriatric-specific and patient-centered outcomes, such as physical function or cognition, 
may also be appropriate outcomes for domain-specific GA studies.
In all GA with management research in the oncogeriatric population, the reasons underlying 
limited or failed intervention studies should be evaluated. Previous studies in older non-
cancer patients’ demonstrated multiple barriers to the development and implementation of 
GA with management in the clinical research setting. Table 2 outlines potential pitfalls in 
developing and executing clinical trials evaluating geriatric interventions.
2.3. Gap 3: What Clinical Trial Design is Optimal for Evaluation of ga with Management in 
Cancer Care?
In non-cancer patients, a design where geriatricians utilize GA to identify areas of 
vulnerability and develop specific management recommendations (protocol-based, GA-
based management) to improve outcomes is called a standardly tailored intervention.8,9 
Examples of geriatric management include recommending physical therapy and home safety 
evaluation for an individual with history of falls,10 or delirium prevention by avoiding high-
risk medications in at-risk individuals.11 Using GA to guide standardly tailored management 
interventions is a potential avenue for improving outcomes for older adults with cancer. 
Repeating GA at time points along the disease trajectory may also offer new opportunities 
for interventions as risk factors arise.
When designing a study evaluating GA with management in cancer care, several approaches 
can be considered. First, investigators could evaluate each specific geriatric management 
intervention separately. An example is a randomized trial evaluating the impact of exercise 
in patients with impaired physical function. Evaluating a specific geriatric management 
intervention independently allows for understanding of the individual impact of each 
specific intervention to ameliorate the risk factor and ultimately the ability to identify those 
management interventions that are of “highest impact,” that are the most feasible to 
implement, and that provide the largest improvement in outcomes. A specific management 
intervention may actually provide benefit in more than one domain, as these domains are not 
necessarily biologically or psychosocially independent. For example, implementing “Meals 
on Wheels” services may help patients with impaired nutritional status as well as those with 
poor social support, mobility limitations, and difficulties accessing nutritious food. However, 
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there are several limitations to this approach. Management interventions are not typically 
developed in isolation in clinical practice. For example, for patients with a history of falls, a 
multicomponent intervention including physical therapy, home safety evaluation, and 
counseling on fall precautions may be recommended and may act additively or 
synergistically. Therefore, evaluating each management intervention individually may not 
reveal their combined overall impact. In complex older patients with cancer, individuals 
often have multiple impairments in GA domains at baseline, and evaluating a single 
management intervention in this population may underestimate the potential impact of a 
comprehensive, multicomponent management intervention.9 Furthermore, these complex 
patients may develop new impairments over the course of a trial and should undergo a repeat 
GA at the time of blinded outcome assessment.
Alternatively, investigators could use a “domain-based” approach and study management 
interventions for a specific GA domain. For example, investigators could identify individuals 
with cognitive impairment and evaluate the benefit of a multicomponent management 
intervention including delirium prevention counseling, caregiver engagement, social work 
referral, and limiting treatment complexity. The benefit of investigating management 
interventions in a domain-based approach is that this strategy addresses an identified GA 
impairment in a more comprehensive fashion. However, this approach may limit the ability 
to determine which specific management intervention has the greatest benefit. Also, this 
approach does not address impairments in other GA domains that could be biologically 
linked (e.g., sarcopenia resulting from poor diet, mobility limitations, and cognition), thus 
potentially limiting impact.
Investigators may also consider evaluating the impact of a more comprehensive GA with 
management program, with multicomponent interventions targeting all domains. This 
strategy would involve a full baseline GA with development of management interventions 
that target any and all identified impairments. This application of GA with management 
allows for a global assessment of the patient, which may inform treatment decision making.
One design for evaluating impact of a GA with management program is to utilize an expert 
in geriatric oncology to develop and deliver the management interventions. This approach 
captures the finer nuances of clinical judgment utilized with complex, older patients with 
cancer. This population also commonly has comorbid conditions, which require careful 
consideration and management during cancer care. A clinician with expertise in evaluating 
and assessing the severity of the comorbid conditions and developing interventions to 
support the patient in this area may be helpful. GA with management encompasses not only 
the physical interventions (i.e., physical therapy, nutritional referral, etc.) but also the 
adaptive medical decision making (i.e., modifications in regimen or dosing due to 
comorbidity, absence of social support, etc.). Adaptive trials designs, such as sequential, 
multiple assignment, randomized trial (SMART31) designs, are used to construct adaptive 
management interventions and allows augmentation of initial treatment for non-responders. 
Benefits to assessing GA with management programs in this approach are that the 
magnitude of benefit from each intervention may be additive and adaptive medical decisions 
are responsive to change. One drawback to evaluating GA with management in this 
approach is that the relative lack of experts in geriatric oncology means that this strategy is 
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not readily applicable to routine clinical practice. Table 3 summarizes the various potential 
approaches to evaluating GA with management in cancer care.
3. Conclusion
It is feasible to incorporate GA into routine oncology care. GA is influential in decision 
making, and elements of the GA can predict chemotherapy toxicity. However, utilization of 
GA in oncology clinical practice remains limited, likely because geriatric management 
interventions have not been robustly studied in this heterogeneous population. GA with 
management is effective at improving outcomes in older non-cancer patients, and 
randomized clinical trials are needed to evaluate the potential feasibility and impact in the 
oncogeriatric population. Several clinical trial design options are available, with varying 
advantages and limitations as outlined above. The field of geriatric oncology is poised to 
move forward to investigate the benefit of GA with management in this population.
Acknowledgments
A Hurria has served as a consultant for GTx, Boehringer Ingelheim, Carevive, and Optum Health Solutions. She 
also has research funding from Celgene, GlaxoSmithKline, and Novartis. S Mohile has served as a consultant for 
Seattle Genetics.
This work was funded by the National Institute on Aging (grant no. U13 AG038151). The work was also funded by 
the American Cancer Society and a Patient-Centered Outcomes Research Institute (PCORI) program contract 
(4634). The work received support from the James Wilmot Cancer Institute (WCI), the Alliance for Clinical Trials 
in Oncology (National Cancer Institute of the National Institutes of Health under the U10CA18082 and 
1UG1CA189823 awards), and the National Cancer Institute (UG1 CA18961). This work was made possible by the 
generous donors to the WCI geriatric oncology philanthropy fund. All statements in this report, including its 
findings and conclusions, are solely those of the authors, do not necessarily represent the official views of the 
funding agencies, and do not necessarily represent the views of the Patient-Centered Outcomes Research Institute 
(PCORI), its Board of Governors or Methodology Committee.
Additionally, this work was funded by the National Cancer Institute R25CA102618 (Magnuson), the Wilmot 
Research Fellowship Award (Magnuson), and the Susan H Green Memorial Grant (Magnuson).
REFERENCES
1. Hurria A, Wildes T, Blair SL, et al. Senior adult oncology, version 2.2014: clinical practice 
guidelines in oncology. J Natl Compr Canc Netw. 2014; 12:82–126. [PubMed: 24453295] 
2. Hurria A, Gupta S, Zauderer M, et al. Developing a cancer-specific geriatric assessment: a 
feasibility study. Cancer. 2005; 104:1998–2005. [PubMed: 16206252] 
3. Chapman AE, Swartz K, Schoppe J, Arenson C. Development of a comprehensive multidisciplinary 
geriatric oncology center, the Thomas Jefferson University experience. J Geriatr Oncol. 2014; 
5:164–170. [PubMed: 24495585] 
4. Williams GR, Deal AM, Jolly TA, et al. Feasibility of geriatric assessment in community oncology 
clinics. J Geriatr Oncol. 2014; 5:245–251. [PubMed: 24703978] 
5. Hurria A, Togawa K, Mohile SG, et al. Predicting chemotherapy toxicity in older adults with cancer: 
a prospective multicenter study. J Clin Oncol. 2011; 29:3457–3465. [PubMed: 21810685] 
6. Extermann M, Boler I, Reich RR, et al. Predicting the risk of chemotherapy toxicity in older 
patients: the Chemotherapy Risk Assessment Scale for High-Age Patients (CRASH) score. Cancer. 
2011
7. Hamaker ME, Schiphorst AH, ten Bokkel Huinink D, Schaar C, van Munster BC. The effect of a 
geriatric evaluation on treatment decisions for older cancer patients—a systematic review. Acta 
Oncol. 2014; 53:289–296. [PubMed: 24134505] 
Magnuson et al. Page 8
J Geriatr Oncol. Author manuscript; available in PMC 2016 August 02.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
8. Allore HG, Tinetti ME, Gill TM, Peduzzi PN. Experimental designs for multicomponent 
interventions among persons with multifactorial geriatric syndromes. Clin Trials. 2005; 2:13–21. 
[PubMed: 16279575] 
9. Allore HG, Murphy TE. An examination of effect estimation in factorial and standardly-tailored 
designs. Clin Trials. 2008; 5:121–130. [PubMed: 18375650] 
10. Tinetti ME. Clinical practice. preventing falls in elderly persons. N Engl J Med. 2003; 348:42–49. 
[PubMed: 12510042] 
11. Inouye SK, Bogardus ST Jr, Charpentier PA, et al. A multicomponent intervention to prevent 
delirium in hospitalized older patients. N Engl J Med. 1999; 340:669–676. [PubMed: 10053175] 
12. Frese T, Deutsch T, Keyser M, Sandholzer H. In-home preventive comprehensive geriatric 
assessment (CGA) reduces mortality—a randomized controlled trial. Arch Gerontol Geriatr. 2012; 
55:639–644. [PubMed: 22790107] 
13. Caplan GA, Williams AJ, Daly B, Abraham K. A randomized, controlled trial of comprehensive 
geriatric assessment and multidisciplinary intervention after discharge of elderly from the 
emergency department—the DEED II study. J Am Geriatr Soc. 2004; 52:1417–1423. [PubMed: 
15341540] 
14. Ellis G, Whitehead MA, O’Neill D, Langhorne P, Robinson D. Comprehensive geriatric 
assessment for older adults admitted to hospital. Cochrane Database Syst Rev. 2011:CD006211. 
[PubMed: 21735403] 
15. Cohen HJ, Feussner JR, Weinberger M, et al. A controlled trial of inpatient and outpatient geriatric 
evaluation and management. N Engl J Med. 2002; 346:905–912. [PubMed: 11907291] 
16. Tikkanen P, Lonnroos E, Sipila S, Nykanen I, Sulkava R, Hartikainen S. Effects of comprehensive 
geriatric assessment-based individually targeted interventions on mobility of pre-frail and frail 
community-dwelling older people. Geriatr Gerontol Int. 2015; 15:80–88. [PubMed: 24397847] 
17. Lihavainen K, Sipila S, Rantanen T, Kauppinen M, Sulkava R, Hartikainen S. Effects of 
comprehensive geriatric assessment and targeted intervention on mobility in persons aged 75 years 
and over: a randomized controlled trial. Clin Rehabil. 2012; 26:314–326. [PubMed: 22007041] 
18. Lustosa LP, Silva JP, Coelho FM, Pereira DS, Parentoni AN, Pereira LS. Impact of resistance 
exercise program on functional capacity and muscular strength of knee extensor in pre-frail 
community-dwelling older women: a randomized crossover trial. Rev Bras Fisioter. 2011; 15:318–
324. [PubMed: 21971726] 
19. Lihavainen K, Sipila S, Rantanen T, et al. Effects of comprehensive geriatric intervention on 
physical performance among people aged 75 years and over. Aging Clin Exp Res. 2012; 24:331–
338. [PubMed: 23238308] 
20. Daniel K. Wii-hab for pre-frail older adults. Rehabil Nurs. 2012; 37:195–201. [PubMed: 
22744992] 
21. Gillespie LD, Robertson MC, Gillespie WJ, et al. Interventions for preventing falls in older people 
living in the community. Cochrane Database Syst Rev. 2012; 9:CD007146. [PubMed: 22972103] 
22. Nykanen I, Rissanen TH, Sulkava R, Hartikainen S. Effects of individual dietary counseling as part 
of a comprehensive geriatric assessment (CGA) on nutritional status: a population-based 
intervention study. J Nutr Health Aging. 2014; 18:54–58. [PubMed: 24402390] 
23. Keeler EB, Robalino DA, Frank JC, Hirsch SH, Maly RC, Reuben DB. Cost-effectiveness of 
outpatient geriatric assessment with an intervention to increase adherence. Med Care. 1999; 
37:1199–1206. [PubMed: 10599601] 
24. Kalsi T, Babic-Illman G, Ross PJ, et al. The impact of comprehensive geriatric assessment 
interventions on tolerance to chemotherapy in older people. Br J Cancer. 2015; 112:1435–1444. 
[PubMed: 25871332] 
25. Bourdel-Marchasson I, Blanc-Bisson C, Doussau A, et al. Nutritional advice in older patients at 
risk of malnutrition during treatment for chemotherapy: a two-year randomized controlled trial. 
PLoS One. 2014; 9:e108687. [PubMed: 25265392] 
26. Goodwin JS, Satish S, Anderson ET, Nattinger AB, Freeman JL. Effect of nurse case management 
on the treatment of older women with breast cancer. J Am Geriatr Soc. 2003; 51:1252–1259. 
[PubMed: 12919237] 
Magnuson et al. Page 9
J Geriatr Oncol. Author manuscript; available in PMC 2016 August 02.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
27. McCorkle R, Strumpf NE, Nuamah IF, et al. A specialized home care intervention improves 
survival among older post-surgical cancer patients. J Am Geriatr Soc. 2000; 48:1707–1713. 
[PubMed: 11129765] 
28. Rao AV, Hsieh F, Feussner JR, Cohen HJ. Geriatric evaluation and management units in the care of 
the frail elderly cancer patient. J Gerontol A Biol Sci Med Sci. 2005; 60:798–803. [PubMed: 
15983186] 
29. Nipp R, Sloane R, Rao AV, Schmader KE, Cohen HJ. Role of pain medications, consultants, and 
other services in improved pain control of elderly adults with cancer in geriatric evaluation and 
management units. J Am Geriatr Soc. 2012; 60:1912–1917. [PubMed: 23036028] 
30. Mohile SG, Velarde C, Hurria A, et al. Geriatric assessment-guided care processes for older adults: 
a Delphi consensus of geriatric oncology experts. J Natl Compr Canc Netw. 2015; 13:1120–1130. 
[PubMed: 26358796] 
31. Murphy SA, Collins LM, Rush AJ. Customizing treatment to the patient: adaptive treatment 
strategies. Drug Alcohol Depend. 2007; 88(Suppl 2):S1–S3. [PubMed: 17350181] 
Magnuson et al. Page 10
J Geriatr Oncol. Author manuscript; available in PMC 2016 August 02.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Magnuson et al. Page 11
Table 1
Summary of GA management recommendations from U.S.-based geriatric oncology experts through Delphi 
process.30
GA domain
impaired
Examples of GA impairment GA with management recommendations by
Delphi consensus
Physical function • History of falls
• Impaired objective physical 
performance testing
• Impaired ADLs or IADLs
• Physical therapy
• Occupational therapy
• Home safety evaluation
• Fall risk assessment
• Modification of cancer treatment regimen
• Improving function prior to treatment 
initiation
Nutrition • Recent weight loss or 
anorexia
• Positive Mini-nutritional 
Assessment screen
• Nutrition consult
• Oral care
• Dietary recommendations
• Evaluating drug tolerance
Cognition • Abnormal cognitive testing 
(e.g., Mini Mental Status 
Examination [MMSE], 
Montreal Cognitive 
Assessment [MOCA])
• Involvement of caregivers
• Delirium prevention
• Social work referral
• Capacity evaluation
• Healthcare proxy designation
• Limiting treatment complexity
• Assessing the presence of caregiver support
Social support • Patient lives alone or 
without significant family 
involvement
• Social work referral
• Home health referral
• Transportation assistance
• Caregiver support services
• Home safety evaluation
• Consideration of modified treatment
Psychological • Positive Geriatric 
Depression Scale (GDS) 
screen
• Positive distress screen
• Social work referral
• Counseling referral
• Psychiatry/psychology referral
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Table 2
Potential pitfalls in clinical trials evaluating GA with management.
Potential pitfalls in clinical trials evaluating GA with
management
1 GA Results are not initially captured
2 GA results and management recommendations are not delivered to the treating provider
3 GA management recommendations are not implemented by the treating provider
4 Patients refuse intervention/do not participate
5 GA with management has limited impact
6 Outcome measurements are not sensitive to detect the impact of GA with management interventions
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Table 3
Summary of potential approaches to evaluating GA with management in cancer care.
Method Example Advantage Disadvantage
Intervention-based
approach
Evaluation of 
counseling referral
for patients with 
positive
depression screen
1 Determine the impact 
of each individual 
intervention
1 Impairments in other 
domains not 
addressed
2 Multiple interventions 
may be considered 
for a single 
impairment thus 
implementing only 
one may limit impact
GA domain-based
approach
Evaluating impact of 
nutrition
consult, nutritional 
supplements,
and oral care for 
patients with
impaired nutrition
1 Determine impact of 
each individual GA 
domain
2 Accounts for multiple 
interventions being 
utilized for single 
impairment
1 Does not account for 
impairments in GA 
domains not 
addressed which may 
limit impact
Full GA with
multicomponent
intervention using
geriatrician/geriatric
oncologist
Geriatrician/geriatric 
oncologist
reviews GA 
findings, develops
multicomponent 
intervention
plan and implements
interventions
1 Incorporates all 
potential impairments
2 Accounts for clinical 
judgment as 
geriatrician/geriatric 
oncologist is 
evaluating full impact 
of GA
3 High likelihood of 
intervention 
implementation based 
upon prior literature
1 Not readily 
transferrable to 
routine clinical 
practice given limited 
number of 
geriatricians/geriatric 
oncologists
Full GA with
multicomponent
intervention using
algorithm
Support staff 
administers and
scores GA, 
algorithm used to
identify appropriate 
interventions
based upon GA 
impairments
1 Incorporates all 
potential impairments
2 Model could be used 
in routine clinical 
practice where 
geriatric oncology 
expert not available
1 Does not account for 
clinical judgment of 
full GA
2 Low likelihood of 
intervention 
implementation based 
upon prior literature
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